In this issue:
Amantadine vs acetylsalicylic acid for MS fatigue
Oligoclonal bands and MS prognosis
Fingolimod reduces MRI outcomes in relapsing-remitting MS
Reduced cancer risk in MS
Atorvastatin + interferon beta in relapsing MS
Rituximab for r
Please login below to download this issue (PDF)